Angiotensin II Receptor Blocker Ameliorates Stress-Induced Adipose Tissue Inflammation and Insulin Resistance

PLoS ONE ◽

10.1371/journal.pone.0116163 ◽

2014 ◽

Vol 9 (12) ◽

pp. e116163 ◽

Author(s):

Motoharu Hayashi ◽

Kyosuke Takeshita ◽

Yasuhiro Uchida ◽

Koji Yamamoto ◽

Ryosuke Kikuchi ◽

...

Keyword(s):

Insulin Resistance ◽

Adipose Tissue ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Adipose Tissue Inflammation ◽

Angiotensin Ii Receptor ◽

Tissue Inflammation

Download Full-text

Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance

10.1016/j.metabol.2003.12.021 ◽

2004 ◽

Vol 53 (6) ◽

pp. 777-781 ◽

Author(s):

Futoshi Anan ◽

Naohiko Takahashi ◽

Tatsuhiko Ooie ◽

Masahide Hara ◽

Hironobu Yoshimatsu ◽

...

Keyword(s):

Insulin Resistance ◽

Angiotensin Ii ◽

Left Ventricular Hypertrophy ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor

Download Full-text

The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2008.07.003 ◽

2008 ◽

Vol 82 (1) ◽

pp. 127-131 ◽

Author(s):

Akiko Yamana ◽

Mikio Arita ◽

Machi Furuta ◽

Yoshinori Shimajiri ◽

Tokio Sanke

Keyword(s):

Insulin Resistance ◽

Type 2 Diabetes ◽

Angiotensin Ii ◽

Glycemic Control ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Beneficial Effects

Download Full-text

Angiotensin II receptor blocker suppresses the Oxidative Stress, Tissue Inflammation, and Atrial Electrical Remodeling in the Canine Experimental Model

Journal of Molecular and Cellular Cardiology ◽

10.1016/j.yjmcc.2008.09.633 ◽

2008 ◽

Vol 45 (4) ◽

pp. S13

Author(s):

H. Fukaya ◽

S. Niwano ◽

H. Niwano ◽

Y. Masaki ◽

M. Kiryu ◽

...

Keyword(s):

Oxidative Stress ◽

Angiotensin Ii ◽

Experimental Model ◽

Receptor Blocker ◽

Electrical Remodeling ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Tissue Inflammation

Download Full-text

Olmesartan Medoxomil, an Angiotensin II Receptor Blocker Ameliorates Insulin Resistance and Decreases Triglyceride Production in Fructose-Fed Rats

Hypertension Research ◽

10.1291/hypres.27.293 ◽

2004 ◽

Vol 27 (4) ◽

pp. 293-299 ◽

Author(s):

Kenta OKADA ◽

Tsutomu HIRANO ◽

Jianmin RAN ◽

Mitsuru ADACHI

Keyword(s):

Insulin Resistance ◽

Angiotensin Ii ◽

Olmesartan Medoxomil ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor

Download Full-text

The Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle

Cardiorenal Medicine ◽

10.1159/000353155 ◽

2013 ◽

Vol 3 (2) ◽

pp. 154-164 ◽

Author(s):

Guido Lastra ◽

Fernando R. Santos ◽

Payam Hooshmand ◽

Paria Hooshmand ◽

Irina Mugerfeld ◽

...

Keyword(s):

Insulin Resistance ◽

Skeletal Muscle ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

The Novel ◽

Angiotensin Ii Receptor ◽

Rat Skeletal Muscle ◽

Azilsartan Medoxomil

Download Full-text

Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis

Journal of Gastroenterology ◽

10.1007/s00535-009-0042-x ◽

2009 ◽

Vol 44 (6) ◽

pp. 583-591 ◽

Author(s):

Junji Yokozawa ◽

Takashi Sasaki ◽

Kumiko Ohwada ◽

Yayoi Sasaki ◽

Jun-Itsu Ito ◽

...

Keyword(s):

Insulin Resistance ◽

Angiotensin Ii ◽

Hepatic Steatosis ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Down Regulation ◽

Stearoyl Coa Desaturase

Download Full-text

Effect of angiotensin-II receptor blocker candesartan alone or in combination with aldoster-one antagonist spironolactone on diastolic function in patients with chronic heart failure and relatively no

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(08)60438-5 ◽

2008 ◽

Vol 7 ◽

pp. 159-159

Author(s):

F AGEEV ◽

O SVIRIDA ◽

A OVCHINNIKOV

Keyword(s):

Heart Failure ◽

Angiotensin Ii ◽

Chronic Heart Failure ◽

Diastolic Function ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor

Download Full-text

Hepatic IL-1 signaling in NAFLD is a driver of whole-body insulin resistance and adipose tissue inflammation.

10.1055/s-0039-3402163 ◽

2020 ◽

Author(s):

N Gehrke ◽

BK Straub ◽

A Waisman ◽

D Schuppan ◽

MA Wörns ◽

...

Keyword(s):

Insulin Resistance ◽

Adipose Tissue ◽

Adipose Tissue Inflammation ◽

Tissue Inflammation

Download Full-text

248-LB: Deficiency of APPL1 in Macrophages Triggers Adipose Tissue Inflammation and Insulin Resistance by Potentiating NLRP3 Inflammasome Activation

Diabetes ◽

10.2337/db19-248-lb ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 248-LB ◽

Author(s):

KELVIN K.L. WU ◽

AIMIN XU ◽

KENNETH K. CHENG

Keyword(s):

Insulin Resistance ◽

Adipose Tissue ◽

Nlrp3 Inflammasome ◽

Inflammasome Activation ◽

Adipose Tissue Inflammation ◽

Tissue Inflammation ◽

Nlrp3 Inflammasome Activation

Download Full-text

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)

BMC Cardiovascular Disorders ◽

10.1186/1471-2261-6-39 ◽

2006 ◽

Vol 6 (1) ◽

Author(s):

Ryuzo Kawamori ◽

Hiroyuki Daida ◽

Yasushi Tanaka ◽

Katsumi Miyauchi ◽

Akira Kitagawa ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Evaluation Trial

Download Full-text